Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

European Commission approves Vectibix for expanded indications

Nov. 16, 2011

SymBio announces plan for new study of SyB L-0501 in multiple myeloma

Nov. 16, 2011

Novel haspin inhibitors designed by Brigham & Women's Hospital

Nov. 16, 2011

New Rho-associated protein kinase inhibitors patented

Nov. 15, 2011

U.S. universities synthesize novel HIF-1 inhibitors

Nov. 15, 2011

Cancer therapy Lipotecan advances through first-in-human trial

Nov. 15, 2011

Pharmacokinetics and safety of E-7050 assessed in humans

Nov. 14, 2011

Canadian organization prepares novel protein kinase inhibitors

Nov. 11, 2011

Daiichi Sankyo licenses protein kinase inhibitor from ArQule for phase I development

Nov. 11, 2011

Boehringer Ingelheim presents novel PDK1 inhibitors

Nov. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...